0000000000275535

AUTHOR

Jana Seifert

showing 5 related works from this author

Effects of HIV, antiretroviral therapy and prebiotics on the active fraction of the gut microbiota

2018

In a recent blinded randomized study, we found that in HIV-infected individuals a short supplementation with prebiotics (scGOS/lcFOS/glutamine) ameliorates dysbiosis of total gut bacteria, particularly among viremic untreated patients. Our study goal was to determine the fraction of the microbiota that becomes active during the intervention and that could provide additional functional information.A total of six healthy individuals, and 16 HIV-infected patients comprising viremic untreated patients (n = 5) and antiretroviral therapy-treated patients that are further divided into immunological responders (n = 7) and immunological nonresponders (n = 4) completed the 6-week course of prebiotic …

DNA Bacterial0301 basic medicine030106 microbiologyImmunologyHuman immunodeficiency virus (HIV)HIV InfectionsGut floramedicine.disease_causeDNA Ribosomallaw.inventionPlacebos03 medical and health sciencesPharmacotherapyImmune systemRandomized controlled triallawRNA Ribosomal 16SmedicineCluster AnalysisHumansImmunology and AllergyPhylogenyBacteriabiologybusiness.industrySequence Analysis DNAMiddle Agedmedicine.diseasebiology.organism_classificationAntiretroviral therapyGastrointestinal MicrobiomeGlutaminePrebiotics030104 developmental biologyInfectious DiseasesAnti-Retroviral AgentsImmunologybusinessDysbiosisFollow-Up StudiesAIDS
researchProduct

Functional consequences of microbial shifts in the human gastrointestinal tract linked to antibiotic treatment and obesity

2013

The microbiomes in the gastrointestinal tract (GIT) of individuals receiving antibiotics and those in obese subjects undergo compositional shifts, the metabolic effects and linkages of which are not clearly understood. Herein, we set to gain insight into these effects, particularly with regard to carbohydrate metabolism, and to contribute to unravel the underlying mechanisms and consequences for health conditions. We measured the activity level of GIT carbohydrate-active enzymes toward 23 distinct sugars in adults patients (n = 2) receiving 14-d β-lactam therapy and in obese (n = 7) and lean (n = 5) adolescents. We observed that both 14 d antibiotic-treated and obese subjects showed higher …

MaleobesityAnabolismAntibioticsBody Mass Indexmetabolic reconstructionantibiotic therapySystems and Synthetic Biology2. Zero hungerSysteem en Synthetische Biologie0303 health sciencesGastrointestinal tractMicrobiotaHuman gastrointestinal tractGastroenterologyBiotaAnti-Bacterial Agents3. Good healthInfectious Diseasesmedicine.anatomical_structureglycosidaseCarbohydrate MetabolismFemaleResearch PaperAdultMicrobiology (medical)medicine.medical_specialtyAdolescentmedicine.drug_classCarbohydrate metabolismBiologyMicrobiology03 medical and health sciencesInsulin resistanceInternal medicinemedicineHumansMicrobiomeObesityVLAGAged030304 developmental biologyMetabolic reconstruction030306 microbiologyAntibiotic therapymedicine.diseaseObesityGlycosidaseGastrointestinal TractDistal gutEndocrinologyHyperglycemiaInsulin Resistancedistal gut
researchProduct

Gut microbiota disturbance during antibiotic therapy: a multi-omic approach

2014

It is known that the gastrointestinal tract (GIT) microbiota responds to different antibiotics in different ways and that while some antibiotics do not induce disturbances of the community, others drastically influence the richness, diversity, and prevalence of bacterial taxa. However, the metabolic consequences thereof, independent of the degree of the community shifts, are not clearly understood. In a recent article, we used an integrative OMICS approach to provide new insights into the metabolic shifts caused by antibiotic disturbance. The study presented here further suggests that specific bacterial lineage blooms occurring at defined stages of antibiotic intervention are mostly associa…

MaleAnabolismAntibioticsGene ExpressionGut floraGastrointestinal FunctionBioinformaticsprokaryotesFecesRNA Ribosomal 16SSystems and Synthetic Biologyhuman fecal microbiota1506MetaproteomicGut Microbiotadatabase2. Zero hungerlong-term impactsGastrointestinal tract0303 health sciencesSysteem en Synthetische Biologiehuman intestinal microbiotabiologyMicrobiotaGastroenterologyBiodiversity3. Good healthAnti-Bacterial AgentsBacterial Typing TechniquesArticle AddendumRNA BacterialInfectious DiseasesMetabolomecommunitymetaproteomicsHuman gut microbiotaMicrobiology (medical)DNA BacterialDisturbance (geology)medicine.drug_classperturbationMetabolomicbeta-LactamsMicrobiologyMicrobiologyresistance03 medical and health sciencesMetagenomicAntibiotic therapyMetabolomemedicineHumans030304 developmental biologyAgedVLAGBacteria030306 microbiologyGene Expression ProfilingColonic MicrofloraAkkermansiaAntibiotic therapybiology.organism_classificationGastrointestinal TractEnterococcusGene Expression RegulationMetaproteomicsMetatranscriptomicGastrointestinal functionmetabolismMeta-Analysis
researchProduct

Gut Bacteria Metabolism Impacts Immune Recovery in HIV-infected Individuals.

2016

While changes in gut microbial populations have been described in human immuno-deficiency virus (HIV)-infected patients undergoing antiretroviral therapy (ART), the mechanisms underlying the contributions of gut bacteria and their molecular agents (metabolites and proteins) to immune recovery remain unexplored. To study this, we examined the active fraction of the gut microbiome, through examining protein synthesis and accumulation of metabolites inside gut bacteria and in the bloodstream, in 8 healthy controls and 29 HIV-infected individuals (6 being longitudinally studied). We found that HIV infection is associated to dramatic changes in the active set of gut bacteria simultaneously alter…

0301 basic medicineMale030106 microbiologylcsh:MedicineInflammationHIV InfectionsGut microbiotaGut floraGeneral Biochemistry Genetics and Molecular BiologyVirusMicrobiology03 medical and health sciencesMedicine General & InternalImmunityAntiretroviral Therapy Highly ActivemedicineMetabolomeHumansMetabolomicsImmune recoveryBiologyMetaproteomelcsh:R5-920biologyBacteriaGastrointestinal Microbiomelcsh:RImmunityHIVGeneral MedicineViral Loadbiology.organism_classificationCD4 Lymphocyte CountGastrointestinal MicrobiomeAntiretroviral therapy030104 developmental biologyCase-Control StudiesImmunologyHIV-1MetabolomeFemalemedicine.symptomlcsh:Medicine (General)Viral loadBacteriaBiomarkersResearch PaperEBioMedicine
researchProduct

HIV infection results in metabolic alterations in the gut microbiota different from those induced by other diseases.

2016

Imbalances in gut bacteria have been associated with multiple diseases. However, whether there are disease-specific changes in gut microbial metabolism remains unknown. Here, we demonstrate that human immunodeficiency virus (HIV) infection (n=33) changes, at quantifiable levels, the metabolism of gut bacteria. These changes are different than those observed in patients with the auto-immune disease systemic lupus erythaematosus (n=18), and Clostridium difficile-associated diarrhoea (n=6). Using healthy controls as a baseline (n=16), we demonstrate that a trend in the nature and directionality of the metabolic changes exists according to the type of the disease. The impact on the gut microbia…

0301 basic medicineMetabolite030106 microbiologyMicrobial metabolismHIV InfectionsDiseaseBiologyGut floraArticle03 medical and health scienceschemistry.chemical_compoundMetabolic flux analysismedicineMetabolomeHumansskin and connective tissue diseasesMultidisciplinaryBacteriaMiddle Agedmedicine.diseasebiology.organism_classificationMetabolic Flux AnalysisGastrointestinal MicrobiomeGastrointestinal Tract030104 developmental biologychemistrySpainImmunologyMetabolomeDysbiosissense organsDysbiosisFlux (metabolism)Scientific reports
researchProduct